1. Home
  2. CYTK vs WULF Comparison

CYTK vs WULF Comparison

Compare CYTK & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$70.05

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Logo TeraWulf Inc.

WULF

TeraWulf Inc.

HOLD

Current Price

$17.83

Market Cap

6.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
WULF
Founded
1997
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
6.8B
IPO Year
2004
1999

Fundamental Metrics

Financial Performance
Metric
CYTK
WULF
Price
$70.05
$17.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
13
Target Price
$85.59
$17.58
AVG Volume (30 Days)
1.5M
33.8M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
3.49
40.00
EPS
N/A
N/A
Revenue
$13,368,000.00
N/A
Revenue This Year
$341.94
$29.53
Revenue Next Year
$48.30
$122.61
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.31
$2.06
52 Week High
$70.98
$17.70

Technical Indicators

Market Signals
Indicator
CYTK
WULF
Relative Strength Index (RSI) 56.80 57.17
Support Level $59.23 $11.30
Resistance Level $67.75 $16.39
Average True Range (ATR) 2.38 1.60
MACD 0.33 0.01
Stochastic Oscillator 79.93 72.73

Price Performance

Historical Comparison
CYTK
WULF

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

Share on Social Networks: